Lipocine (LPCN) Shares Outstanding (2016 - 2025)
Historic Shares Outstanding for Lipocine (LPCN) over the last 12 years, with Q3 2025 value amounting to $5.4 million.
- Lipocine's Shares Outstanding rose 135.22% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year increase of 135.22%. This contributed to the annual value of $5.3 million for FY2024, which is 60.4% up from last year.
- Latest data reveals that Lipocine reported Shares Outstanding of $5.4 million as of Q3 2025, which was up 135.22% from $5.4 million recorded in Q2 2025.
- In the past 5 years, Lipocine's Shares Outstanding ranged from a high of $88.3 million in Q1 2021 and a low of $5.2 million during Q4 2021
- Moreover, its 5-year median value for Shares Outstanding was $5.3 million (2023), whereas its average is $18.4 million.
- Per our database at Business Quant, Lipocine's Shares Outstanding surged by 8449.81% in 2021 and then plummeted by 9407.17% in 2022.
- Over the past 5 years, Lipocine's Shares Outstanding (Quarter) stood at $5.2 million in 2021, then increased by 0.25% to $5.2 million in 2022, then grew by 1.55% to $5.3 million in 2023, then grew by 0.6% to $5.3 million in 2024, then rose by 1.35% to $5.4 million in 2025.
- Its Shares Outstanding was $5.4 million in Q3 2025, compared to $5.4 million in Q2 2025 and $5.4 million in Q1 2025.